Orion Oyj Logo

Orion Oyj

Develops, manufactures, and markets human and veterinary pharmaceuticals and APIs.

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO

Description

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-25 14:30
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Mark…
English 5.7 KB
2024-04-25 10:00
Orion Group Interim Report January-March 2024
Finnish 546.5 KB
2024-04-25 10:00
Orion Group Interim Report January-March 2024
English 543.1 KB
2024-03-22 10:30
Change in Orion Group Executive Management Board: change in Orion's group-level…
Finnish 3.1 KB
2024-03-22 10:30
Change in Orion Group Executive Management Board: change in Orion's group-level…
English 3.2 KB
2024-03-20 15:00
Orion Corporation: Organising meeting of the Board of Directors
Finnish 3.2 KB
2024-03-20 15:00
Orion Corporation: Organising meeting of the Board of Directors
English 3.4 KB
2024-03-20 14:50
Decisions taken by Orion Corporation's Annual General Meeting on 20 March 2024
Finnish 10.2 KB
2024-03-20 14:50
Decisions taken by Orion Corporation's Annual General Meeting on 20 March 2024
English 11.2 KB
2024-03-04 11:00
Orion Corporation: Managers' transactions - Hao Pan
Finnish 3.0 KB
2024-03-04 11:00
Orion Corporation: Managers' transactions - Hao Pan
English 3.1 KB
2024-03-01 16:50
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
Finnish 3.0 KB
2024-03-01 16:50
Orion Corporation: Transfer of 150,118 own B shares on 1 March 2024
English 3.2 KB
2024-02-26 12:30
Orion Group Financial Statement documents 2023, Corporate Governance Statement …
Finnish 3.0 MB
2024-02-26 12:30
Orion Group Financial Statement documents 2023, Corporate Governance Statement …
Finnish 1.9 MB

Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Orion Oyj

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Orion Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.